Weight loss in a murine cachexia model is not associated with the cytokines tumour necrosis factor-α or interleukin-6

This publication has 17 references indexed in Scilit:

• Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice.
  Journal of Clinical Investigation, 1991
• Elevated Circulating Interleukin-6 Is Associated with an Acute-phase Response but Reduced Fixed Hepatic Protein Synthesis in Patients with Cancer
  Annals of Surgery, 1991
• Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
  Journal of Clinical Investigation, 1990
• Tumor necrosis factor‐α and interleukin‐1α production in cachectic, tumor‐bearing mice
  International Journal of Cancer, 1990
• Functional discrimination between interleukin 6 and interleukin 1
  European Journal of Immunology, 1988
• Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor
  British Journal of Cancer, 1988
• Tumors secreting human TNF/cachectin induce cachexia in mice
  Cell, 1987
• Cachectin and tumour necrosis factor as two sides of the same biological coin
  Nature, 1986
• Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin
  Science, 1985
• Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease.
  Journal of Clinical Pathology, 1983